Literature DB >> 6518294

Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancer.

G Wang, C L Vogel, S G Hilsenbeck, W Voigt, S Thomsen.   

Abstract

Using sucrose gradient centrifugation, human breast cancer estrogen receptors appear in two molecular forms sedimenting at either 8S or 4S fractions. The sum of these two fractions has been valuable clinically in helping to predict response to hormonal therapies. It has been suggested that the 4S receptor may not be of predictive value and that the practice of using only dextran-coated charcoal methodology might thus overestimate the number of patients whose tumors might be hormonally dependent. The present study correlates clinical response to hormonal manipulations with 8S and 4S receptors as determined by sucrose density gradient centrifugation. Patients with only 4S positive receptors had a 56% response rate to hormonal manipulation compared with a 52% response rate in patients with positive 8S alone or with both 8S and 4S receptors. Although patient numbers are small in this and the other three published series addressing this question, our data do not confirm two previously published studies suggesting clinical importance of 8S/4S fractionation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6518294     DOI: 10.1007/bf01806040

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

Review 1.  Endocrine therapy of breast cancer.

Authors:  W L McGuire
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Estrogen receptors and hormone dependency in human breast cancer.

Authors:  J L Wittliff; B W Beatty; E D Savlov; W B Patterson; R A Cooper
Journal:  Recent Results Cancer Res       Date:  1976

4.  Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.

Authors:  J L Hayward; P P Carbone; J C Heuson; S Kumaoka; A Segaloff; R D Rubens
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

5.  Estrogen receptors and breast cancer response to adrenalectomy.

Authors:  E V Jensen; G E Block; S Smith; K Kyser; E R DeSombre
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

6.  Comparison of dextran-coated charcoal and sucrose density gradient analyses of estrogen and progesterone receptors in human breast cancer.

Authors:  K M Anderson; P Bonomi; M Marogil; C Hendrickson; S Economou
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

7.  Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.

Authors:  T E Kute; P Heidemann; J L Wittliff
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

8.  Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast.

Authors:  T L Dao; T Nemoto
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  Comparison of sex steroid receptor analyses and carcinoembryonic antigen with clinical response to hormone therapy.

Authors:  K S McCarty; C Cox; J S Silva; B H Woodard; J A Mossler; D E Haagensen; T K Barton; K S McCarty; S A Wells
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

10.  Steroid receptor interactions in human breast carcinoma.

Authors:  J L Wittliff
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

  10 in total
  1 in total

1.  Predictors of hormone response for patients with ER-unknown breast tumours.

Authors:  V Hug; H Thames; S Bentzen
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.